Gene Query: LONP2

Dataset Description Geneva Score
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 39.61
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 38.94
miR941 overexpression experiment 34.22
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 33.77
Transcriptional effect of ETV1 knockdown in melanoma cells 33.26
Next generation sequencing of small RNAs isolated from exosomes in human semen 24.02
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 22.69
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 21.28
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 20.9
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.69
Lipid degradation promotes prostate cancer cell survival 17.83
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 17.28
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 16.74
Cell responses to dysregulated VZV-induced cell-cell fusion 16.35
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 15.88
Gene expression analysis of immortalized human liver progenitor-like cells in culture 15.35
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 14.84
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 14.36
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 14.29
Identification of Nrf2 regulated genes by RNA sequencing 14.25
Nrf2 regulated genes in A549 cells 14.25
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 14.2
TGF-β regulation of miRNA expression in pancreatic cancer 13.98
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 13.85
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 13.84
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 13.79
Genome wide expression change in LCC2 and MCF-7 cells 13.78
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 13.78
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 13.42
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.17
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 12.93
RNA-seq analyses of human prostate cancer cells 12.83
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.65
circRNA-sequencing 12.42
RNA-seq of YB5 cells treated with Proscillaridin A 12.37
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.35
Role of XRN2 ribonucleolytic activity in RNA metabolism 12.18
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 11.95
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 11.94
Role of microRNAs in the interaction between Salmonella and the host cell 11.84
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.47
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 11.35
Genome wide miR-191 target profile determined by RIP and gene expression profiling 11.34
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 11.34
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 11.23
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 11.15
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.14
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.11
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.58
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.58
Global gene expression profile of dasatinib-resistant RCH-ACV cells 10.56
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.56
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 10.41
METTL3 promotes translation in human cancer cells 10.33
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 10.27
Effect of Influenza virus infection on lncRNA expression in A549 cells 10.2
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 10.2
Differential Gene Expression between MCF10A and MCF7 cells 10.05
Gene expression changes after LOC550643 silencing 9.96
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 9.85
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 9.79
Genome-wide identification of cancer-specific alternative splicing in circRNA 9.61
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.53
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 9.52
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 9.48
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.46
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 9.38
Chromatin-informed inference of transcriptional programs in gynecologic cancers 9.38
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 9.37
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.31
Patient-derived luminal breast cancer xenografts with progestins 9.31
MYC dependent mRNA translation shapes gene expression and cell biology 9.2
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 9.2
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 9.1
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 8.99
MeRIP-seq for heat shock in B-cell lymphoma cells 8.99
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 8.94
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.92
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.91
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.87
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 8.77
Aneuploidy triggers an immune response 8.71
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.68
IMP3 regulated gene expression in breast cancer cells 8.66
Human cells contain natural double-stranded RNAs with potential regulatory capacity 8.61
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 8.43
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 8.34
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 8.34
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 8.32
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 8.32
Disruption of the exocyst induces podocyte loss and dysfunction 8.23
RNA-seq of tumor cells following angiopellosis extravasation 8.2
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.16
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 8.14
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.09
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 8.04
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 7.91
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 7.84
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 7.83
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.82
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.76
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.7
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.63
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 7.62
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 7.62
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.61
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.57
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 7.55
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 7.55
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.51
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 7.46
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.42
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 7.4
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 7.38
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 7.3
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 7.3
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.28
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 7.27
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.18
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.12
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.1
RNA seq comparison between scrambled and shGRP78 cells 7.1
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.06
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 7.06
CD73 knockdown effect in pancreatic cancer cell lines 7.0
RNAseq Study in CC-671 Treated Cal-51 Cells 6.99
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 6.91
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 6.9
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.9
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.9
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.9
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.88
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.88
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.88
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 6.87
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 6.78
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.75
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.73
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 6.69
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 6.69
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 6.68
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.67
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 6.66
CROP-Seq in Primary Human T Cells 6.64
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 6.64
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 6.64
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.59
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.56
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.53
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.53
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 6.5
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 6.48
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 6.48
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 6.48
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.47
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.47
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.43
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 6.39
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.37
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 6.35
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.35
3’ Uridylation Expands miRNA Target Repertoire 6.33
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 6.31
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.3
Genome-wide chromatin analysis of Ewing sarcoma 6.3
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 6.3
Fbxo32 mediated gene expression program underlies EMT and metastasis 6.27
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 6.24
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.22
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.22
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.22
Transcriptome of activated human and mouse MAIT cells 6.21
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 6.21
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 6.21
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.21
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 6.19
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 6.19
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.16
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.14
Transcriptome analysis of H9 hESC derived cerebral organoids 6.12
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 6.11
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.1
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 6.07
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 6.07
Global response to chemotherapy-induced apoptosis 6.0
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.0
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.98
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 5.97
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 5.97
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 5.97
RNA-seq analysis of BAP1-depleted uveal melanoma cells 5.97
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.95
Mapping interactions for the TNIP2 hub protein 5.95
Knockdown of ADNP in HCT116 colon cancer cells 5.92
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 5.89
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.89
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 5.89
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.88
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.82
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 5.74
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 5.74
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 5.74
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.69
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.69
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.68
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 5.66
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 5.66
Transcriptomic analyssis following EHMT1/2 inhibition 5.63
Genes significantly down or Up-regulated upon RNF219 knockdown 5.62
Transcriptomic analysis of the HOTAIR-regulated genes 5.61
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 5.6
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 5.6
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.53
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 5.49
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 5.38
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.37
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.33
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.26
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 5.1
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 5.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.97
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.91
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 4.91
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 4.9
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.87
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.86
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 4.82
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 4.82
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.82
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.81
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.8
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.8
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 4.73
K562 polyA RNA-Seq 4.72
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.69
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 4.69
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 4.69
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.68
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.68
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.67
Human HAP1 cells before and after nutrient deprivation 4.65
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 4.65
X-Ray induced DNA-Hydroxymethylation changes 4.64
SLIGRL-induced gene expression changes in NHEK cells 4.61
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.56
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.55
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.54
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 4.48
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 4.48
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 4.46
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.45
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 4.43
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.41
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.4
Transcriptomic analysis of human tonsillar TFH subsets 4.36
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.33
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.33
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.33
PTHrP overexpression in MCF7 cells 4.3
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.29
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 4.28
Gene expression in GBM with Cav3.2 inhibition 4.25
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.23
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 4.21
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.19
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 4.14
RNA-sequencing 4.13
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.13
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.09
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 4.09
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 4.08
RNA polymerase in pre-B-ALL cell lines 4.0
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.99
Transcriptome analysis of CNS leukemia 3.97
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 3.97
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.96
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.95
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 3.93
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.9
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.9
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 3.88
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 3.87
RNA Sequencing of Human iPS derived Cardiomyocytes 3.8
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.79
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.78
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.78
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.78
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.78
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.77
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.65
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.65
RNA-seq of RKO cells with cTAZ KO or putback 3.63
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.62
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.61
Regulatory network controlling tumor-promoting inflammation in human cancers 3.58
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.58
SOX11 knockdown in B-ALL cell lines 3.57
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.54
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.51
Human Treg NaCl stimulation 3.5
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 3.47
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.42
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.38
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.36
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.36
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.35
Argonaute proteins couple chromatin silencing to alternative splicing 3.34
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.34
RNA sequencing of primary human platelets and in vitro cell lines 3.33
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 3.29
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 3.28
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 3.28
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 3.25
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 3.23
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.23
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.23
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.14
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.13
The age and genomic integrity of neurons after cortical stroke in humans 3.08
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.07
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.07
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.06
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 3.05
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 3.05
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.04
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.99
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.99
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.98
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.95
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.92
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.9
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.89
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.82
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.82
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.81
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.78
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.75
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.69
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.63
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.63
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.63
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.6
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.58
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.58
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.57
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.57
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.54
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.51
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.5
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.5
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 2.48
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.47
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.46
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 2.44
RNA seq_PDX2_SHP099 2.44
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.41
Transcriptomic profiling of human peripheral blood-derived mast cells 2.39
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.39
Gene expression analysis of human hepatocellular cancers 2.38
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.34
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.33
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.33
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.29
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 2.26
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.26
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.24
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.24
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 2.24
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.22
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.19
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.16
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.13
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.11
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.11
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.09
Gene expression profile in breast cancer cells 2.09
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.08
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.08
Copper Regulation of HIF-1 Transcription Activity 2.08
4sUDRB-seq: measuring transcription elongation and initiation genomewide 2.01
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.0
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.92
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.92
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.91
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.9
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 1.89
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 1.89
Metabolism as an early predictor of DPSCs aging 1.89
Dysregulated immune system networks in war veterans with PTSD 1.87
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.84
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.83
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.8
Transcriptomic analysis of LSD1 1.79
naive T cell heterogeneity after neonatal thymectomy 1.75
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.74
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.71
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.71
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.71
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.71
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.6
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.59
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.59
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.53
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.53
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.48
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.45
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.44
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.43
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.4
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.4
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.38
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.36
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.35
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.3
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.3
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.28
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.27
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.21
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.18
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.18
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.18
Myc activation coordinates gene transcription and protein translation responses 1.17
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.15
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.14
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.14
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.14
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.12
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.1
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.1
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.03
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.98
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.97
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.96
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.91
Human Tfh cell RNA bulk sequencing 0.9
Gene expression analysis of human adenomas. 0.89
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 0.88
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.87
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.86
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.85
Transcriptome analysis of peripheral blood monocytes 0.84
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.75
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.73
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.73
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.72
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.72
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.68
The cohesin release factor WAPL restricts chromatin loop extension. 0.68
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.68
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.67
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.65
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.65
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.58
Dilated cardiomyopathy vs Myocarditis 0.56
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.53
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.53
RNA-seq data 0.48
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.43
Triple vectors expand AAV transfer capacity in the retina 0.4
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.39
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.39
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.36
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.36
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.34
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.34
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.34
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.34
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.34
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.32
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.31
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.3
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.29
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.29
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.24
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.23
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.22
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.22
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.2
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.2
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.2
Energy Metabolism during Anchorage-Independence 0.2
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.13
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.11
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 0.11
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.11
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.11
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.09
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.07
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.07
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.06
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.03
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.02
Interphase condensins regulate ligand-depedent enhancer activation 0.02
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.02
Aging-associated patterns in the expression of human endogenous retroviruses 0.02
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.02
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation